A comparative study of patient adherence vis-Ã -vis treatment outcome in supervised versus non-supervised artesunate/sulphadoxine - pyrimethamine administration in uncomplicated falciparum malaria

Dr Chiranjib Bagchi Calcutta School of Tropical Medicine0 个研究点目标入组 62 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Inclusion Criteria
•Presence of acute symptomatic uncomplicated malaria with a diagnosis confirmed by a positive blood smear with asexual forms of P falciparum parasites only (without mixed infection).
•Only those of the above patients considered eligible by the physician at the Malaria Clinic, for dispensation of AS-SP plus primaquine treatment as per the national guidelines (NVBDCP).
•Adult patients (age > 18 years) â?? both sexes
•Patients willing to give informed consent.
•Patients considered able to comply with the study protocol for the duration of the study.
•Patients residing within a reasonable distance of the site, so that attendance of all study visits and follow-up by medical staff are logistically feasible.

•Exclusion Criteria
•Mixed infection with another Plasmodium species at the time of presentation (including P vivax, P ovale and P malariae)
•Known allergy to artesunate, artemisinin derived products, sulphadoxine, pyremethamine, primaquine or any other related drugs.
•G6PD deficiency as investigated by the G6PD test

发起方

Dr Chiranjib Bagchi Calcutta School of Tropical Medicine